IP Library Granted Patent US 7,405,289
Granted Patent B2
US 7,405,289 · App. 10/533,593 · Granted Jul 29, 2008

Pancreatic islet transcription factor and uses thereof

Assignee: Metabolex, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,405,289
App. No.
10/533,593
Granted
Jul 29, 2008
Kind
B2
Abstract

The present invention provides a pancreatic islet transcription factor and methods of treating and diagnosing diabetes.

Claims (18)

1. An isolated nucleic acid encoding an IC-RFX polypeptide comprising SEQ ID NO:2.

2. The nucleic acid of claim 1 , wherein the nucleic acid comprises SEQ ID NO:1.

3. An isolated nucleic acid encoding a polypeptide comprising in the following order: a proline/glutamine rich domain, an RFX DNA binding domain (SEQ ID NO:4), an RFX B domain (SEQ ID NO:5), an RFX C domain (SEQ ID NO:6), a dimerization domain (SEQ ID NO:7) and a serine/threonine domain.

4. An expression cassette comprising a promoter operably linked to the nucleic acid of claim 1 or claim 3 .

5. An isolated host cell transfected with the nucleic acid of claim 1 or claim 3 .

6. The host cell of claim 5 , wherein the cell is a pancreatic islet cell.

7. The host cell of claim 6 , wherein the cell is an islet β-cell.

8. A method of detecting a polynucleotide in a subject, the method comprising

detecting in a sample from the subject a polynucleotide encoding a polypeptide comprising in the following order: a proline/glutamine rich domain, an RFX DNA binding domain (SEQ ID NO:4), an RFX B domain (SEQ ID NO:5), an RFX C domain (SEQ ID NO:6), a dimerization domain (SEQ ID NO:7) and a serine/threonine domain.

9. The method of claim 8 , wherein the polynucleotide is detected by hybridization.

10. The method of claim 8 , wherein the polynucleotide is detected by amplification of the polynucleotide.

11. The method of claim 8 , wherein the nucleotide sequence of the polynucleotide is determined.

12. A method of introducing an expression cassette into an isolated cell, the method comprising,

introducing into the cell an expression cassette comprising a promoter operably linked to a polynucleotide encoding a polypeptide, the polypeptide comprising in the following order: a proline/glutamine rich domain, an RFX DNA binding domain (SEQ ID NO:4), an RFX B domain (SEQ ID NO:5), an FRX C domain (SEQ ID NO:6), a dimerization domain (SEQ ID NO:7) and a serine/threonine domain.

13. The method of claim 12 , wherein the polypeptide comprises SEQ ID NO:2.

14. The method of claim 12 , wherein the polynucleotide comprises SEQ ID NO:1.

15. The method of claim 12 , wherein the cell is a pancreatic islet cell.

16. The method of claim 12 , wherein the cell is an islet β-cell.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Aug 7, 2015
From: SILICON VALLEY BANK; OXFORD FINANCE LLC
To: CYMABAY THERAPEUTICS, INC.
Reel/Frame 036307/0406 →
SECURITY AGREEMENT Recorded Nov 22, 2013
From: CYMABAY THERAPEUTICS, INC.
To: SILICON VALLEY BANK; OXFORD FINANCE LLC
Reel/Frame 031710/0508 →
CHANGE OF NAME Recorded Oct 30, 2013
From: METABOLEX, INC.
To: CYMABAY THERAPEUTICS, INC.
Reel/Frame 031516/0699 →
Continuity (2)
Provisional Application 6042596800 · Nov 13, 2002
Related Publication 20060264611A1 · Nov 23, 2006